252 related articles for article (PubMed ID: 27887797)
1. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
Landow SM; Gjelsvik A; Weinstock MA
J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
[TBL] [Abstract][Full Text] [Related]
2. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
3. Melanoma thickness trends in the United States, 1988-2006.
Criscione VD; Weinstock MA
J Invest Dermatol; 2010 Mar; 130(3):793-7. PubMed ID: 19829301
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
Lo SN; Scolyer RA; Thompson JF
Ann Surg Oncol; 2018 Apr; 25(4):894-902. PubMed ID: 29330716
[TBL] [Abstract][Full Text] [Related]
5. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
6. Early detection of thick melanomas in the United States: beware of the nodular subtype.
Demierre MF; Chung C; Miller DR; Geller AC
Arch Dermatol; 2005 Jun; 141(6):745-50. PubMed ID: 15967921
[TBL] [Abstract][Full Text] [Related]
7. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
10. Morphologic Forms and Classification of Dermal Mitotic Figure Density in Primary Cutaneous Melanoma: A Retrospective Study.
Marsch AF; McKee RM; Hinds BR
Am J Dermatopathol; 2020 Jan; 42(1):35-40. PubMed ID: 31884499
[TBL] [Abstract][Full Text] [Related]
11. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
Claeson M; Gillstedt M; Whiteman DC; Paoli J
Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
[TBL] [Abstract][Full Text] [Related]
12. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
13. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
14. Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.
Gimotty PA; Shore R; Lozon NL; Whitlock J; He S; Vigneau FD; Dickie L; Elder DE; Xu X; Schwartz AG; Guerry D
J Invest Dermatol; 2016 Nov; 136(11):2168-2172. PubMed ID: 27354265
[TBL] [Abstract][Full Text] [Related]
15. Prognostication in thin cutaneous melanomas.
Gimotty PA; Guerry D
Arch Pathol Lab Med; 2010 Dec; 134(12):1758-63. PubMed ID: 21128772
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.
Ma Q; Suo H; Zhu L; Qian Y; Sun X; Xie J; Li Q; Fu Y; Li J; Tao J
Cancer Med; 2020 Jul; 9(13):4561-4571. PubMed ID: 32367684
[TBL] [Abstract][Full Text] [Related]
17. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
18. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
[TBL] [Abstract][Full Text] [Related]
19. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
